- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 261/00 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
Patent holdings for IPC class C07D 261/00
Total number of patents in this class: 24
10-year publication summary
|
3
|
0
|
1
|
1
|
0
|
0
|
0
|
1
|
3
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bayer Animal Health GmbH | 168 |
2 |
| Immunic AG | 71 |
2 |
| F. Hoffmann-La Roche AG | 7795 |
1 |
| Samsung Display Co., Ltd. | 39229 |
1 |
| Merck Sharp & Dohme Corp. | 2183 |
1 |
| E. I. du Pont de Nemours and Company | 3439 |
1 |
| Janssen Pharmaceutica N.V. | 3137 |
1 |
| Pfizer Inc. | 3423 |
1 |
| Syngenta Participations AG | 1474 |
1 |
| Syngenta Limited | 422 |
1 |
| Life Technologies Corporation | 3463 |
1 |
| The Johns Hopkins University | 5957 |
1 |
| Arvinas, Inc. | 23 |
1 |
| Cellixbio Private Limited | 142 |
1 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 787 |
1 |
| Medshine Discovery Inc. | 587 |
1 |
| University of Virginia Patent Foundation | 1657 |
1 |
| Wincom, Inc. | 15 |
1 |
| Zalicus Pharmaceuticals Ltd. | 13 |
1 |
| Qingdao Kingagroot Chemical Compound Co., Ltd. | 244 |
1 |
| Other owners | 2 |